ArticleEmerging infectious diseases2021
Use of Genomics to Track Coronavirus Disease Outbreaks, New Zealand.
Article in Emerging infectious diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 20 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
20 citing papers in PubMed.
- Time series anomaly detection in helpline call trends for early detection of COVID-19 spread across Sweden, 2020.Scientific reports · 2025Article
- In silico analyses identify sequence contamination thresholds for Nanopore-generated SARS-CoV-2 sequences.PLoS computational biology · 2024Article
- Integrated Genomic and Social Network Analyses of SARS-CoV-2 Transmission in the Healthcare Setting.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2024Article
- Investigating the rise of Omicron variant through genomic surveillance of SARS-CoV-2 infections in a highly vaccinated university population.Microbial genomics · 2024Article
- Exploring the depth and breadth of the genomics toolbox during the COVID-19 pandemic: insights from Aotearoa New Zealand.BMC medicine · 2023Review
- The August 2020 COVID-19 outbreak in Aotearoa, New Zealand: Delayed contact tracing for Pacific people contributes to widening health disparities.IJID regions · 2023Article
- Public health interventions successfully mitigated multiple incursions of SARS-CoV-2 Delta variant in the Australian Capital Territory.Epidemiology and infection · 2023Article
- Pangenome graphs in infectious disease: a comprehensive genetic variation analysis ofFrontiers in genetics · 2023Article
- Tracing the international arrivals of SARS-CoV-2 Omicron variants after Aotearoa New Zealand reopened its border.Nature communications · 2022Article
- Genomic epidemiology of Delta SARS-CoV-2 during transition from elimination to suppression in Aotearoa New Zealand.Nature communications · 2022Article
- Airborne Transmission of SARS-CoV-2 Delta Variant within Tightly Monitored Isolation Facility, New Zealand (Aotearoa).Emerging infectious diseases · 2022Review
- Ultraviolet-C Irradiation, Heat, and Storage as Potential Methods of Inactivating SARS-CoV-2 and Bacterial Pathogens on Filtering Facepiece Respirators.Pathogens (Basel, Switzerland) · 2022Article
- Detection of SARS-CoV-2 infection clusters: The useful combination of spatiotemporal clustering and genomic analyses.Frontiers in public health · 2022Article
- Monitoring International Travelers Arriving in Hong Kong for Genomic Surveillance of SARS-CoV-2.Emerging infectious diseases · 2022Article
- Article
- The lag in SARS-CoV-2 genome submissions to GISAID.Nature biotechnology · 2021Article
- Real-Time Genomics for Tracking Severe Acute Respiratory Syndrome Coronavirus 2 Border Incursions after Virus Elimination, New Zealand.Emerging infectious diseases · 2021Article
- We should not dismiss the possibility of eradicating COVID-19: comparisons with smallpox and polio.BMJ global health · 2021Article
- Transmission of Severe Acute Respiratory Syndrome Coronavirus 2 during Border Quarantine and Air Travel, New Zealand (Aotearoa).Emerging infectious diseases · 2021Review
- Phylodynamics reveals the role of human travel and contact tracing in controlling the first wave of COVID-19 in four island nations.Virus evolution · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Real-time genomic sequencing has played a major role in tracking the global spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), contributing greatly to disease mitigation strategies. In August 2020, after having eliminated the virus, New Zealand experienced a second outbreak. During that outbreak, New Zealand used genomic sequencing in a primary role, leading to a second elimination of the virus. We generated genomes from 78% of the laboratory-confirmed samples of SARS-CoV-2 from the second outbreak and compared them with the available global genomic data. Genomic sequencing rapidly identified that virus causing the second outbreak in New Zealand belonged to a single cluster, thus resulting from a single introduction. However, successful identification of the origin of this outbreak was impeded by substantial biases and gaps in global sequencing data. Access to a broader and more heterogenous sample of global genomic data would strengthen efforts to locate the source of any new outbreaks.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.